Avidity Biosciences
RNAM
#1854
Rank
A$16.10 B
Marketcap
A$104.29
Share price
0.00%
Change (1 day)
102.83%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$16.10 Billion

As of July 2026 Avidity Biosciences has a market cap of A$16.10 Billion. This makes Avidity Biosciences the world's 1854th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$16.10 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$200.42 B 1,144.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$146.73 B 810.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.34 B-85.43%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$9.22 B-42.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.40 B-97.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.65 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.52 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA